Litcius/Paper detail

Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement

Wen‐Hsiang Chen, Xinrong Tao, Anurodh Shankar Agrawal, Abdullah Algaissi, Bi-Hung Peng, Jeroen Pollet, Ulrich Strych, María Elena Bottazzi, Peter J. Hotez, Sara Lustigman, Lanying Du, Shibo Jiang, Chien‐Te K. Tseng

2020Vaccine108 citationsDOIOpen Access PDF

Topics & Concepts

VirologyBiologyAntibodyRecombinant DNAAdjuvantNeutralizing antibodyCoronavirusImmune systemProtein subunitAntibody titerTiterImmunityImmunologyMicrobiologyCoronavirus disease 2019 (COVID-19)MedicineGeneBiochemistryPathologyDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyCOVID-19 Clinical Research Studies
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement | Litcius